Influenza B virus neuraminidase: a potential target for next-generation vaccines?
ABSTRACTIntroduction Influenza B viruses (IBV) cause a significant health and economic burden annually. Due to lower antigenic drift rate, less extensive antigenic diversity, and lack of animal reservoirs, the development of highly effective universal vaccines against IBV might be in reach. Current...
Main Authors: | Thi Hoai Thu Do, Adam K. Wheatley, Stephen J. Kent, Marios Koutsakos |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2023.2290691 |
Similar Items
-
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
by: Madhusudan Rajendran, et al.
Published: (2021-08-01) -
Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
by: Nada Abbadi, et al.
Published: (2023-01-01) -
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
by: Sarah Creytens, et al.
Published: (2021-11-01) -
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
by: Luca T. Giurgea, et al.
Published: (2020-07-01) -
Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01)